Kalypsys

Kalypsys, Inc., a clinical stage pharmaceutical company, engages in the discovery and development of small molecular drugs. The company integrates capabilities in drug discovery, medicinal chemistry, and translational medicine with automated technologies to discover and develop small molecule drugs. It focuses on cardiovascular/metabolic, pain/inflammation, and oncology diseases. The company was founded in 2001 and is based in San Diego, California. Kalypsys Systems is a unit of Kalypsys that designs, develops and markets proprietary automated systems and workstations for the drug discovery market. The centerpiece of the Kalypsys suite of technologies is a proprietary state-of-the-art automated robotic ultra-high throughput screening and profiling system. This system allows scientists to accurately and reliably interrogate targets in 1536 well-based biochemical and disease-relevant cellular assays.